Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

被引：0
|
作者：
Chris Skedgel
Daniel Rayson
Tallal Younis
机构：
[1] University of East Anglia,Norwich Medical School
[2] Capital Health,Atlantic Clinical Cancer Research Unit
[3] Capital Health,Department of Medicine
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Breast cancer; Febrile neutropenia; Granulocyte colony-stimulating factors; Economic evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 394
页数：7
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF LONG ACTING GRANULOCYTE COLONY STIMULATING FACTOR FOR PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA IN BREAST CANCER IN THE RUSSIA
    Krysanov, I
    Tiapkina, M.
    VALUE IN HEALTH, 2016, 19 (07) : A734 - A734
  • [42] Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
    Ashrafi, Farzaneh
    Salmasi, Mehrzad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2018, 23
  • [43] The effect of primary granulocyte-colony stimulating factor prophylaxis on incidence of febrile neutropenia in patients with testicular germ cell tumors.
    Hapakova, Nikola
    Chovanec, Michal
    Rejlekova, Katarina
    Kalavska, Katarina
    Obertova, Jana
    Palacka, Patrik
    De Angelis, Valentina
    Sycova, Zuzana
    Mardiak, Jozef
    Mego, Michal
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] The cost-effectiveness of primary prophylaxis with granulocyte colony-stimulating factor in docetaxel-containing adjuvant chemotherapy in early breast cancer: The impact of risk of febrile neutropenia and its mortality
    Chan, K. K.
    Trudeau, M. E.
    Eisen, A.
    Verreault, J. L.
    Freedman, C. A.
    Dent, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Colony-stimulating factors: Clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia
    Raposo C.G.
    Marín Á.P.
    Barón M.G.
    Clinical and Translational Oncology, 2006, 8 (10) : 729 - 734
  • [46] Primary prophylaxis of febrile neutropenia with granulocyte-colony stimulating factor in patient with locally advanced non-small cell lung cancer - case report
    Knetki-Wroblewska, Magdalena
    Kowalski, Dariusz M.
    ONCOLOGY IN CLINICAL PRACTICE, 2012, 8 (02): : 57 - 59
  • [47] Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
    Wojtukiewicz, Marek
    Chmielowska, Ewa
    Filipczyk-Cisarz, Emilia
    Krzemieniecki, Krzysztof
    Lesniewski-Kmak, Krzysztof
    Litwiniuk, Maria M.
    Wieruszewska-Kowalczyk, Karolina
    Kosno-Kruszewska, Elzbieta
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (06): : 419 - 424
  • [48] Colony-stimulating factors for chemotherapy-induced febrile neutropenia
    Mhaskar, Rahul
    Clark, Otavio Augusto Camara
    Lyman, Gary
    Botrel, Tobias Engel Ayer
    Paladini, Luciano Morganti
    Djulbegovic, Benjamin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [49] The Impact of Primary Prophylaxis with Granulocyte Colony-Stimulating Factors on Febrile Neutropenia during Chemotherapy: A Systematic Review and MetaAnalysis of Randomized Controlled Trials
    Wang, Li
    Baser, Onur
    Kutikova, Lucie
    Page, John H.
    Barron, Richard L.
    BLOOD, 2014, 124 (21)
  • [50] Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
    Advani, S. H.
    Achreckar, Suvarna
    Thomas, Dennis
    Krishnankutty, Binny
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2010, 31 (03) : 79 - 82
12345